138 related articles for article (PubMed ID: 29085298)
1. Changes in P2Y Purinergic Receptor Expression in the Ciliary Body in a Murine Model of Glaucoma.
Fonseca B; Martínez-Águila A; Pérez de Lara MJ; Miras-Portugal MT; Gómez-Villafuertes R; Pintor J
Front Pharmacol; 2017; 8():719. PubMed ID: 29085298
[TBL] [Abstract][Full Text] [Related]
2. Diadenosine tetraphosphate as a potential therapeutic nucleotide to treat glaucoma.
Fonseca B; Martínez-Águila A; de Lara MJP; Pintor J
Purinergic Signal; 2017 Jun; 13(2):171-177. PubMed ID: 27848070
[TBL] [Abstract][Full Text] [Related]
3. Changes in melatonin receptor expression in a murine model of glaucoma.
Martínez-Águila A; Fonseca B; Pérez de Lara MJ; Miras-Portugal MT; Gómez-Villafuertes R; Carracedo G; Pintor J
Mol Vis; 2020; 26():530-539. PubMed ID: 32818016
[TBL] [Abstract][Full Text] [Related]
4. Investigating the effect of ciliary body photodynamic therapy in a glaucoma mouse model.
Matsubara A; Nakazawa T; Husain D; Iliaki E; Connolly E; Michaud NA; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2498-507. PubMed ID: 16723462
[TBL] [Abstract][Full Text] [Related]
5. Age-related changes in eye morphology and aqueous humor dynamics in DBA/2J mice using contrast-enhanced ocular MRI.
Crosbie DE; Keaney J; Tam LCS; Daniel Stamer W; Campbell M; Humphries P
Magn Reson Imaging; 2019 Jun; 59():10-16. PubMed ID: 30660703
[TBL] [Abstract][Full Text] [Related]
6. Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma.
Fiedorowicz M; Wełniak-Kamińska M; Świątkiewicz M; Orzeł J; Chorągiewicz T; Toro MD; Rejdak R; Bogorodzki P; Grieb P
Front Pharmacol; 2020; 11():573238. PubMed ID: 33013417
[TBL] [Abstract][Full Text] [Related]
7. Loss of P2Y
Hamada K; Shinozaki Y; Namekata K; Matsumoto M; Ohno N; Segawa T; Kashiwagi K; Harada T; Koizumi S
Br J Pharmacol; 2021 Nov; 178(22):4552-4571. PubMed ID: 34309010
[TBL] [Abstract][Full Text] [Related]
8. Effects of Dorzolamide on Retinal and Choroidal Blood Flow in the DBA/2J Mouse Model of Glaucoma.
Chandra S; Muir ER; Deo K; Kiel JW; Duong TQ
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):826-31. PubMed ID: 26934140
[TBL] [Abstract][Full Text] [Related]
9. Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma.
Zhou X; Li F; Kong L; Tomita H; Li C; Cao W
J Biol Chem; 2005 Sep; 280(35):31240-8. PubMed ID: 15985430
[TBL] [Abstract][Full Text] [Related]
10. Purinergic dysregulation causes hypertensive glaucoma-like optic neuropathy.
Shinozaki Y; Kashiwagi K; Namekata K; Takeda A; Ohno N; Robaye B; Harada T; Iwata T; Koizumi S
JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978804
[TBL] [Abstract][Full Text] [Related]
11. Dependency of intraocular pressure elevation and glaucomatous changes in DBA/2J and DBA/2J-Rj mice.
Scholz M; Buder T; Seeber S; Adamek E; Becker CM; Lütjen-Drecoll E
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):613-21. PubMed ID: 18235006
[TBL] [Abstract][Full Text] [Related]
12. A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist.
Jacob TF; Singh V; Dixit M; Ginsburg-Shmuel T; Fonseca B; Pintor J; Youdim MBH; Major DT; Weinreb O; Fischer B
Purinergic Signal; 2018 Sep; 14(3):271-284. PubMed ID: 30019187
[TBL] [Abstract][Full Text] [Related]
13. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma.
Steele MR; Inman DM; Calkins DJ; Horner PJ; Vetter ML
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):977-85. PubMed ID: 16505032
[TBL] [Abstract][Full Text] [Related]
14. Effect of Antiglaucoma Medicine on Intraocular Pressure in DBA/2J Mice.
Sawada K; Hiraoka M; Ohguro H
Ophthalmic Res; 2016; 55(4):205-11. PubMed ID: 26942413
[TBL] [Abstract][Full Text] [Related]
15. The Contribution of Anterior Segment Abnormalities to Changes in Intraocular Pressure in the DBA/2J Mouse Model of Glaucoma: DBA/2J-
Rohowetz LJ; Mardelli ME; Duncan RS; Riordan SM; Koulen P
Front Neurosci; 2021; 15():801184. PubMed ID: 35185449
[TBL] [Abstract][Full Text] [Related]
16. Silencing of P2Y(2) receptors reduces intraocular pressure in New Zealand rabbits.
Martin-Gil A; de Lara MJ; Crooke A; Santano C; Peral A; Pintor J
Br J Pharmacol; 2012 Feb; 165(4b):1163-72. PubMed ID: 21740413
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of extracellular ATP in glaucomatous retinas: Possible role of the vesicular nucleotide transporter during the development of the pathology.
Pérez de Lara MJ; Guzmán-Aránguez A; de la Villa P; Díaz-Hernández JI; Miras-Portugal MT; Pintor J
Mol Vis; 2015; 21():1060-70. PubMed ID: 26392744
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
[TBL] [Abstract][Full Text] [Related]
19. Understanding the Presence and Roles of Ap
Crooke A; Guzman-Aranguez A; Carracedo G; de Lara MJP; Pintor J
J Ocul Pharmacol Ther; 2017; 33(6):426-434. PubMed ID: 28414592
[TBL] [Abstract][Full Text] [Related]
20. Assessment of inner retina dysfunction and progressive ganglion cell loss in a mouse model of glaucoma.
Pérez de Lara MJ; Santano C; Guzmán-Aránguez A; Valiente-Soriano FJ; Avilés-Trigueros M; Vidal-Sanz M; de la Villa P; Pintor J
Exp Eye Res; 2014 May; 122():40-9. PubMed ID: 24631335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
